Abou-Auda HS, 2008, Bipolar Disord, 10, 369, 10.1111/j.1399-5618.2007.00549.x
Adams J, 2000, Acta Psychiatr Scand, 101, 119, 10.1034/j.1600-0447.2000.90061.x
Agarkar S, 2011, J Neuropsychiatry Clin Neurosci, 23, 12, 10.1176/jnp.23.2.jnpe12
Ahlfors UG, 1981, Acta Psychiatr Scand, 64, 226, 10.1111/j.1600-0447.1981.tb00778.x
Allen MH, 2006, Am J Psychiatry, 163, 272, 10.1176/appi.ajp.163.2.272
Altamura AC, 2003, J Affect Disord, 76, 267, 10.1016/S0165-0327(02)00075-7
10.1176/appi.ajp.160.7.1252
Altshuler LL, 2009, J Clin Psychiatry, 70, 450, 10.4088/JCP.08m04191
American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders. 4th revised ed
10.1097/01.yic.0000171519.64080.c9
Amsterdam JD, 2010, Am J Psychiatry, 167, 792, 10.1176/appi.ajp.2009.09020284
10.1097/00004714-199812000-00003
Anderson J, 2000, J Rheumatol, 27, 540
10.1016/S0165-0327(01)00377-9
Angst J, 1981, Handbook of Biological Psychiatry, 225
Angst J, 1995, Schweiz Arch Neurol Psychiatr, 146, 17
10.1080/13811110590929488
10.1001/archpsyc.1967.01730200030005
Baastrup PC, 1970, Lancet, 2, 326, 10.1016/S0140-6736(70)92870-9
Baldessarini RJ, 1999, J Clin Psychiatry, 60, 77, 10.4088/JCP.v60n0202
Baldessarini RJ, 1999, Bipolar Disord, 1, 91, 10.1034/j.1399-5618.1999.010206.x
Baldessarini RJ, 1999, Bipolar Disord, 1, 17, 10.1034/j.1399-5618.1999.10106.x
10.1111/j.1399-5618.2006.00344.x
10.1080/15622970802465807
Bauer MS, 2006, J Clin Psychiatry, 67, 48, 10.4088/JCP.v67n0108
10.1111/j.1600-0447.1976.tb00060.x
Becker D, 2002, Eur Psychiatry, 17, 349, 10.1016/S0924-9338(02)00688-0
Belmaker RH, 2010, World J Biol Psychiatry, 11, 76, 10.3109/15622970903414196
Benabarre A, 2009, Actas Esp Psiquiatr, 37, 143
10.1016/j.biopsych.2008.04.022
Berk M, 2008, J Affect Disord, 106, 153, 10.1016/j.jad.2007.06.011
10.1016/j.jad.2012.01.047
10.1192/bjp.bp.107.037887
Beynon S, 2009, J Psychopharmacol, 23, 574, 10.1177/0269881108093885
Bond DJ, 2008, J Clin Psychiatry, 69, 1589, 10.4088/JCP.v69n1009
10.1016/j.jad.2009.05.014
10.1080/13811110590929541
Bowden CL, 1997, Psychopharmacol Bull, 33, 693
10.1001/archpsyc.57.5.481
10.1001/archpsyc.60.4.392
Bowden CL, 2012, Acta Psychiatry, 64, 1013
Calabrese JR, 1991, J Clin Psychopharmacol, 11, 396, 10.1097/00004714-199112000-00026
Calabrese J, 2003, J Clin
Calabrese JR, 2004, Biol Psychiatry, 56, 957, 10.1016/j.biopsych.2004.09.022
Calabrese JR, 2005, Am J Psychiatry, 162, 2152, 10.1176/appi.ajp.162.11.2152
Calabrese JR, 2006, Biol Psychiatry, 59, 1061, 10.1016/j.biopsych.2006.02.034
10.1111/j.1399-5618.2011.00974.x
10.1016/S0165-0327(02)00046-0
Carta MG, 2006, Clin Pract Epidemiol Ment Health, 2, 19, 10.1186/1745-0179-2-19
Chengappa KN, 2005, Bipolar Disord, 7, 68, 10.1111/j.1399-5618.2004.00171.x
10.1176/appi.ajp.162.10.1805
Colom F, 2006, J Affect Disord, 93, 13, 10.1016/j.jad.2006.01.032
10.1016/j.jad.2008.03.023
Coxhead N, 1992, Acta Psychiatr Scand, 85, 114, 10.1111/j.1600-0447.1992.tb01453.x
Cundall RL, 1972, Psychol Med, 2, 308, 10.1017/S0033291700042616
Denicoff KD, 1997, Am J Psychiatry, 154, 1456, 10.1176/ajp.154.10.1456
Denicoff KD, 1997, J Clin Psychiatry, 58, 470, 10.4088/JCP.v58n1102
Diav-Citrin O, 2005, J Clin Psychiatry, 66, 317, 10.4088/JCP.v66n0307
Dubovsky SL, 2011, Expert Opin Pharmacother, 12, 817, 10.1517/14656566.2011.563237
Duffy A, 2009, BMC Psychiatry, 9, 4, 10.1186/1471-244X-9-4
Dunner DL, 1998, J Clin Psychiatry, 59, 48
10.1001/archpsyc.1974.01760080077013
El-Mallakh RS, 2008, J Affect Disord, 111, 372, 10.1016/j.jad.2008.03.025
Elphick M, 1985, Br J Psychiatry, 147, 198, 10.1192/bjp.147.2.198
Emrich HM, 1992, Prog Neuropsychopharmacol Biol Psychiatry, 16, 691, 10.1016/0278-5846(92)90025-A
Ernst CL, 2002, J Clin Psychiatry, 63, 42
Esparon J, 1986, Br J Psychiatry, 148, 723, 10.1192/bjp.148.6.723
Fagiolini A, 2003, Am J Psychiatry, 160, 112, 10.1176/appi.ajp.160.1.112
10.1111/j.1399-5618.2005.00234.x
Fieve RR, 1976, Am J Psychiatry, 133, 925, 10.1176/ajp.133.8.925
Findling RL, 2012, J Clin Psychiatry, 73, 57, 10.4088/JCP.11m07104
Fitzgerald BJ, 2002, Pharmacotherapy, 22, 1500, 10.1592/phco.22.16.1500.33697
Fountoulakis KN, 2004, Ann Gen Hosp Psychiatry, 3, 10, 10.1186/1475-2832-3-10
Franchini L, 1999, Eur Arch Psychiatry Clin Neurosci, 249, 227, 10.1007/s004060050091
Frangou S, 2006, Br J Psychiatry, 188, 46, 10.1192/bjp.188.1.46
10.1001/archpsyc.1991.01810330075011
10.1016/j.amjmed.2005.11.003
Frye MA, 2011, New Engl J Med, 364, 51, 10.1056/NEJMcp1000402
Frye MA, 1996, J Clin Psychopharmacol, 16, 87, 10.1097/00004714-199602000-00022
Frye MA, 2009, Am J Psychiatry, 166, 164, 10.1176/appi.ajp.2008.08030322
Garcia-Lopez A, 2001, Actas Esp Psiquiatr, 29, 327
Geddes JR, 2004, Am J Psychiatry, 161, 217, 10.1176/appi.ajp.161.2.217
10.1016/S0140-6736(09)61828-6
Ghaemi SN, 2008, Am J Psychiatry, 165, 300, 10.1176/appi.ajp.2007.07121931
10.1097/00004850-199711000-00006
Ghaemi SN, 2004, Ann Clin Psychiatry, 16, 69, 10.1080/10401230490453103
Ghaemi SN, 2006, Psychiatr Serv, 57, 660, 10.1176/ps.2006.57.5.660
Ghaemi SN, 2008, Acta Psychiatr Scand, 118, 347, 10.1111/j.1600-0447.2008.01257.x
Ghaemi SN, 2010, J Clin Psychiatry, 71, 372, 10.4088/JCP.08m04909gre
10.1176/appi.ajp.2007.07030454
10.1001/archgenpsychiatry.2009.159
Gitlin M, 1999, Drug Saf, 20, 231, 10.2165/00002018-199920030-00004
Gitlin MJ, 2010, Curr Med Res Opin, 26, 1835, 10.1185/03007995.2010.489830
10.1111/j.1399-5618.2007.00325.x
Goldberg JF, 2008, Biol Psychiatry, 63, 125, 10.1016/j.biopsych.2006.12.031
Goldsmith DR, 2003, Drugs, 63, 2029, 10.2165/00003495-200363190-00009
Goncalves N, 1985, Nervenarzt, 56, 43
10.1111/j.1399-5618.2006.00368.x
10.1016/j.jad.2010.11.037
Goodwin FK, 2002, J Clin Psychiatry, 63, 5
Goodwin FK, 2007, Manic-depressive illness, 2
Goodwin GM, 1994, Br J Psychiatry, 164, 149, 10.1192/bjp.164.2.149
Goodwin GM, 2008, Eur Neuropsychopharmacol, 18, 787, 10.1016/j.euroneuro.2008.07.005
Grande I, 2012, J Affect Disord, 143, 102, 10.1016/j.jad.2012.05.035
Grande I, 2012, Int J Neuropsychopharmacol, 1
Greil W, 1999, Int Clin Psychopharmacol, 14, 283, 10.1097/00004850-199914050-00003
Greil W, 1999, Int Clin Psychopharmacol, 14, 277, 10.1097/00004850-199914050-00002
Greil W, 1997, Eur Arch Psychiatry Clin Neurosci, 247, 42, 10.1007/BF02916252
Greil W, 1997, J Affect Disord, 43, 151, 10.1016/S0165-0327(96)01427-9
Grof P, 1979, Arch Gen Psychiatry, 36, 891, 10.1001/archpsyc.1979.01780080065015
Grof P, 2010, Neuropsychobiology, 62, 8, 10.1159/000314305
Grof P, 2002, J Clin Psychiatry, 63, 942, 10.4088/JCP.v63n1013
Grunze H, 2002, WPA Series “Evidence Experience in Psychiatry” – Bipolar disorder, 229
Grunze H, 2004, Valproat bei manisch-depressiven (bipolaren) Erkrankungen, 2
Grunze H, 2004, World J Biol Psychiatry, 5, 120, 10.1080/15622970410029924
10.1080/15622970902823202
Grunze H, 2010, World J Biol Psychiatry, 11, 81, 10.3109/15622970903555881
Grunze HC, 2008, CNS Spectr, 13, 790, 10.1017/S1092852900013912
10.3109/09638230903469186
Hakkaart-van Roijen L, 2004, Acta Psychiatr Scand, 110, 383, 10.1111/j.1600-0447.2004.00403.x
Han C, 2007, Prog Neuropsychopharmacol Biol Psychiatry, 31, 1219, 10.1016/j.pnpbp.2007.04.017
Hartong EG, 2003, J Clin Psychiatry, 64, 144, 10.4088/JCP.v64n0206
Harvey PD, 2006, J Clin Psychiatry, 67, 14
Harvey PW, 2008, J Psychopharmacol, 22, 20, 10.1177/0269881107082624
10.1016/S0165-0327(01)00451-7
Hayes SG, 1989, J Clin Psychiatry, 50, 35
10.1176/appi.ajp.163.2.185
10.1001/archgenpsychiatry.2010.199
10.1001/archgenpsychiatry.2011.1456
Hullin RP, 1972, Lancet i, 1044
Hummel B, 2002, Neuropsychobiology, 45, 37, 10.1159/000049260
Jefferson JW, 2010, J Clin Psychiatry, 71, 1153, 10.4088/JCP.09m05917yel
Johannessen SI, 2010, Curr Neuropharmacol, 8, 254, 10.2174/157015910792246254
Johnston AM, 1999, Prevalence and risk factors. Br J Psychiatry, 175, 336, 10.1192/bjp.175.4.336
Johnstone EC, 1990, J Affect Disord, 20, 225, 10.1016/0165-0327(90)90054-C
Jones MW, 1998, Can J Neurol Sci, 25, 13, 10.1017/S0317167100034855
Joyce PR, 1988, Int Clin Psychopharmacol, 3, 123, 10.1097/00004850-198804000-00003
10.1016/S0165-0327(02)00324-5
10.1001/archpsyc.1982.04290090053011
10.1517/14740330802423234
Karayal ON, 2011, J Clin Psychiatry, 72, 367, 10.4088/JCP.10m06281gre
10.1176/appi.ajp.160.4.741
Keck PE, 2005, Int J Psychiaty Clin Practice, 9, 271, 10.1080/13651500500305622
10.1016/j.biopsych.2006.03.056
Kemp DE, 2009, J Clin Psychiatry, 70, 113, 10.4088/JCP.07m04022
Kemp DE, 2012, Eur Neuropsychopharmacol, 22, 123, 10.1016/j.euroneuro.2011.06.005
Kessing LV, 1998, Br J Psychiatry, 172, 23, 10.1192/bjp.172.1.23
Kessing LV, 1998, Psychol Med, 28, 1027, 10.1017/S0033291798006862
Kessing LV, 2011, J Psychopharmacol
10.1192/bjp.bp.110.084822
Ketter TA, 2002, J Clin Psychiatry, 63, 146, 10.4088/JCP.v63n0210
Ketter TA, 2007, J Affect Disord, 100, 45, 10.1016/j.jad.2007.02.006
Kleindienst N, 2007, Int Clin Psychopharmacol, 22, 125, 10.1097/01.yic.0000224788.21406.c8
10.1146/annurev.pharmtox.011008.145557
10.1016/S1043-2760(01)00438-6
Kupka RW, 2003, J Clin Psychiatry, 64, 1483, 10.4088/JCP.v64n1213
10.1176/appi.ajp.162.7.1273
10.1097/YCO.0b013e3281a305ab
Lambert PA, 1984, Anticonvulsants in affective disorders, 33
Lancon C, 1996, Encephale, 22, 468
Lebowitz BK, 2001, Neuropsychiatry Neuropsychol Behav Neurol, 14, 177
Leon AC, 2011, J Clin Psychiatry, 72, 580, 10.4088/JCP.10m06552
10.1176/appi.ajp.163.2.232
10.1136/bmj.332.7555.1444
10.1136/bmj.326.7400.1167
Licht RW, 2012, CNS Neurosci Ther, 18, 219, 10.1111/j.1755-5949.2011.00260.x
Licht RW, 2003, Acta Psychiatr Scand Suppl, 1, 10.1034/j.1600-0447.108.s419.1.x
Licht RW, 2008, Bipolar Disord, 10, 79, 10.1111/j.1399-5618.2008.00499.x
Licht RW, 2010, Bipolar Disord, 12, 483, 10.1111/j.1399-5618.2010.00836.x
10.1001/archpsyc.62.4.361
Loo C, 2011, J Affect Disord, 132, 1, 10.1016/j.jad.2010.08.017
10.1111/j.1399-5618.2010.00835.x
Lopez-Jaramillo C, 2010, J Clin Psychiatry, 71, 1055, 10.4088/JCP.08m04673yel
Lusznat RM, 1988, Br J Psychiatry, 153, 198, 10.1192/bjp.153.2.198
Macfadden W, 2009, Bipolar Disord, 11, 827, 10.1111/j.1399-5618.2009.00761.x
Magalhaes PV, 2011, J Affect Disord, 129, 317, 10.1016/j.jad.2010.08.001
Maier W, 2010, Eur Arch Psychiatry Clin Neurosci, 260, 17, 10.1007/s00406-009-0068-3
Maj M, 2000, Bipolar Disord, 2, 93, 10.1034/j.1399-5618.2000.020202.x
Maj M, 1998, Am J Psychiatry, 155, 30, 10.1176/ajp.155.1.30
Malempati RN, 2008, Int Clin Psychopharmacol, 23, 88, 10.1097/YIC.0b013e3282f2b4c5
Mander AJ, 1988, Lancet, 2, 15, 10.1016/S0140-6736(88)92947-9
10.1016/S0165-0327(98)00110-4
10.1111/j.1399-5618.2011.00898.x
Marneros A, 2001, J Affect Disord, 62, 39, 10.1016/S0165-0327(00)00349-9
10.1111/j.1399-5618.2007.00327.x
Martinez-Aran A, 2008, Bipolar Disord, 10, 566, 10.1111/j.1399-5618.2008.00611.x
McElroy SL, 2008, J Affect Disord, 107, 127, 10.1016/j.jad.2007.08.014
McIntyre RS, 2010, Clin Ther, 32, 32, 10.1016/j.clinthera.2010.01.022
McIntyre RS, 2009, Bipolar Disord, 11, 815, 10.1111/j.1399-5618.2009.00749.x
McIntyre RS, 2010, J Affect Disord, 126, 358, 10.1016/j.jad.2010.04.005
10.1016/S0140-6736(11)61516-X
Melia PI, 1970, Br J Psychiatry, 116, 621, 10.1192/bjp.116.535.621
Meltzer HY, 2003, J Clin Psychiatry, 64, 1122, 10.4088/JCP.v64n0920
10.1176/appi.ajp.2008.08040488
Minnai GP, 2011, J ECT, 27, 123, 10.1097/YCT.0b013e3181dbf797
Mishory A, 2003, Bipolar Disord, 5, 464, 10.1046/j.1399-5618.2003.00070.x
Möller HJ, 2010, Eur Arch Psychiatry Clin Neurosci, 260, 25, 10.1007/s00406-009-0070-9
Moskowitz AS, 1991, J Clin Psychopharmacol, 11, 272, 10.1097/00004714-199108000-00020
Müller-Oerlinghausen B, 2006, Lithium in neuropsychiatry: The comprehensive guide, 179
Murru A, 2011, Eur Psychiatry
Muzina DJ, 2008, Int J Clin Pract, 62, 679, 10.1111/j.1742-1241.2008.01735.x
Neels HM, 2004, Clin Chem Lab Med, 42, 1228, 10.1515/CCLM.2004.245
Newcomer JW, 2007, J Clin Psychiatry, 68, 8, 10.4088/JCP.0307e08
Nguyen HT, 2009, Adv Ther, 26, 281, 10.1007/s12325-009-0011-z
Nielsen J, 2012, Bipolar Disord, 14, 863, 10.1111/bdi.12018
Nierenberg AA, 2008, Biol Psychiatry, 64, 455, 10.1016/j.biopsych.2008.04.036
Nierenberg AA, 2009, Clin Trials, 6, 637, 10.1177/1740774509347399
Nolen WA, 2007, Acta Psychiatr Scand, 115, 360, 10.1111/j.1600-0447.2007.00993.x
Nolen WA, 2008, Richtlijn bipolaire stoornissen, 2
Oquendo MA, 2011, Am J Psychiatry, 168, 1050, 10.1176/appi.ajp.2011.11010163
Pacchiarotti I, 2011, J Affect Disord, 133, 105, 10.1016/j.jad.2011.03.037
Park MH, 2011, Expert Rev Neurother, 11, 1541, 10.1586/ern.11.151
Parker G, 2006, A proof of concept study. J Affect Disord, 92, 205, 10.1016/j.jad.2006.01.024
Passmore MJ, 2003, Bipolar Disord, 5, 110, 10.1034/j.1399-5618.2003.00026.x
10.1176/appi.ajp.162.10.1957
Perova T, 2010, Int J Neuropsychopharmacol, 13, 693, 10.1017/S1461145709000261
Perugi G, 2002, J Clin Psychopharmacol, 22, 584, 10.1097/00004714-200212000-00008
Petrides G, 2011, Neuropsychobiology, 64, 129, 10.1159/000328943
Placidi GF, 1986, J Clin Psychiatry, 47, 490
Popovic D, 2011, Eur Neuropsychopharmacol
Post RM, 1992, Am J Psychiatry, 149, 1727, 10.1176/ajp.149.12.1727
Post RM, 2010, J Clin Psychiatry, 71, 1176, 10.4088/JCP.08m04811yel
Post RM, 2010, J Clin Psychiatry, 71, 864, 10.4088/JCP.08m04994yel
10.1097/01.jcp.0000169068.34322.70
10.1001/archpsyc.1973.01750330035006
10.1001/archpsyc.1973.04200030104017
Prien RF, 1974, Am J Psychiatry, 131, 198, 10.1176/ajp.131.2.198
Puri BK, 1995, Br J Clin Pract, 49, 333, 10.1111/j.1742-1241.1995.tb10004.x
Puzynski S, 1984, Psychopharmacol Bull, 20, 151
Puzynski S, 1984, J Affect Disord, 6, 115, 10.1016/0165-0327(84)90013-2
Quiroz JA, 2010, Biol Psychiatry, 68, 156, 10.1016/j.biopsych.2010.01.015
Quitkin F, 1978, Am J Psychiatry, 135, 570, 10.1176/ajp.135.5.570
Quitkin FM, 1981, Psychopharmacol Bull, 17, 142
Rabheru K, 1997, Can J Psychiatry, 42, 476, 10.1177/070674379704200503
Raucher-Chene D, 2008, J Neurol Sci, 273, 116, 10.1016/j.jns.2008.05.022
Reinares M, 2009, J Affect Disord, 123, 81, 10.1016/j.jad.2009.09.009
Riedel M, 2010, Expert Opin Drug Saf, 9, 659, 10.1517/14740338.2010.486787
Riemann D, 1993, Neuropsychobiology, 27, 163, 10.1159/000118974
Roy-Byrne PP, 1985, Acta Psychiatr Scand Suppl, 317, 1, 10.1111/j.1600-0447.1985.tb10510.x
10.1016/j.schres.2010.07.012
Runge C, 2004, Nervenarzt, 75, 896, 10.1007/s00115-004-1691-x
Rush AJ, 2005, Biol Psychiatry, 58, 355, 10.1016/j.biopsych.2005.05.024
Rybakowski JK, 2010, Int J Neuropsychopharmacol, 13, 617, 10.1017/S1461145710000404
Rybakowski JK, 2001, Bipolar Disord, 3, 63, 10.1034/j.1399-5618.2001.030203.x
Sachdev PS, 1986, Am J Psychiatry, 143, 942, 10.1176/ajp.143.7.942
Sachs GS, 2000, Postgrad Med Spec Report, 1
Sachs GS, 2007, New Engl J Med, 356, 1711, 10.1056/NEJMoa064135
Sartorius N, 2007, Int J Neuropsychopharmacol, 10, 1
Schneck CD, 2002, Curr Treat Options Neurol, 4, 477, 10.1007/s11940-002-0015-3
Scott J, 2007, Int J Neuropsychopharmacol, 10, 123, 10.1017/S1461145706006900
Scott J, 2009, J Clin Psychiatry, 70, 378, 10.4088/JCP.08m04333
Seemuller F, 2005, Expert Opin Drug Saf, 4, 849, 10.1517/14740338.4.5.849
10.1097/WNF.0b013e3182055c07
Serretti A, 2003, Am J Pharmacogenomics, 3, 17, 10.2165/00129785-200303010-00004
Severus WE, 2001, Harv Rev Psychiatry, 9, 280, 10.1080/10673220127910
Severus WE, 2009, J Affect Disord, 115, 466, 10.1016/j.jad.2008.10.009
Severus WE, 2010, Eur Psychiatry, 25, 443, 10.1016/j.eurpsy.2009.10.009
Shelton RC, 2006, Expert Rev Neurother, 6, 33, 10.1586/14737175.6.1.33
Shukla S, 1984, Am J Psychiatry, 141, 1604, 10.1176/ajp.141.12.1604
Simon GE, 2006, Am J Psychiatry, 163, 41, 10.1176/appi.ajp.163.1.41
Singh V, 2012, Bipolar Disord, 14, 13
10.1111/j.1399-5618.2007.00490.x
Solomon DA, 1998, J Clin Psychopharmacol, 18, 38, 10.1097/00004714-199802000-00007
Solomon DA, 2010, Arch Gen Psychiatry, 67, 339, 10.1001/archgenpsychiatry.2010.15
Spina E, 1996, An update. Clin Pharmacokinet, 31, 198, 10.2165/00003088-199631030-00004
Staiano AE, 2012, Int J Obes (London), 36, 1450, 10.1038/ijo.2011.268
Stallone F, 1973, Am J Psychiatry, 130, 1006, 10.1176/ajp.130.9.1006
10.1001/archpsyc.56.5.407
Stone M, 2009, Br Med J, 339, 2880, 10.1136/bmj.b2880
Suppes T, 1993, Harv Rev Psychiatry, 1, 131, 10.3109/10673229309017072
Suppes T, 1994, Biol Psychiatry, 36, 338, 10.1016/0006-3223(94)90631-9
Suppes T, 2004, Int Clin Psychopharmacol, 19, 173, 10.1097/00004850-200405000-00010
Suppes T, 2005, J Affect Disord, 89, 69, 10.1016/j.jad.2005.07.011
Suppes T, 2007, Int Clin Psychopharmacol, 22, 376, 10.1097/YIC.0b013e3281c55f63
10.1176/appi.ajp.2008.08020189
Szabo CP, 1993, S Afr Med J, 83, 442
10.1097/JCP.0b013e31823f872f
Thies-Flechtner K, 1996, Pharmacopsychiatry, 29, 103, 10.1055/s-2007-979553
10.1176/appi.ajp.157.2.220
10.1176/appi.ajp.159.6.1011
10.1176/appi.ajp.160.7.1263
10.1001/archpsyc.60.11.1079
Tohen M, 2003, Am J Psychiatry, 160, 2099, 10.1176/appi.ajp.160.12.2099
10.1176/appi.ajp.162.7.1281
10.1176/appi.ajp.163.2.247
10.1192/bjp.bp.107.041301
10.1111/j.1399-5618.2009.00726.x
Tohen M, 2009, J Affect Disord, 116, 43, 10.1016/j.jad.2008.11.003
Tredget J, 2010, J Affect Disord, 126, 436, 10.1016/j.jad.2010.04.018
Tural U, 2010, Psychiatry Clin Neurosci, 64, 79, 10.1111/j.1440-1819.2009.02042.x
Ulcickas YM, 2010, Pharmacoepidemiol Drug Saf, 19, 1124, 10.1002/pds.2047
Undurraga J, 2012, J Affect Disord, 139, 89, 10.1016/j.jad.2012.01.027
10.1111/j.1528-1157.1994.tb02930.x
van der Loos ML, 2011, Bipolar Disord, 13, 111, 10.1111/j.1399-5618.2011.00887.x
Vencovsky E, 1984, Anticonvulsants in affective disorders, 66
Vernon AC, 2012, Biol Psychiatry, 71, 855, 10.1016/j.biopsych.2011.12.004
10.1016/j.euroneuro.2011.11.011
Vieta E, 2011, New Engl J Med, 364, 1581
10.1111/j.1399-5618.2007.00561.x
10.1034/j.1399-5618.2002.01204.x
Vieta E, 2004, J Clin Psychopharmacol, 24, 374, 10.1097/01.jcp.0000130556.01373.45
Vieta E, 2006, J Clin Psychiatry, 67, 473, 10.4088/JCP.v67n0320
Vieta E, 2008, Int J Neuropsychopharmacol, 11, 445, 10.1017/S1461145708008596
Vieta E, 2008, World J Biol Psychiatry, 9, 219, 10.1080/15622970701530917
10.1016/j.jad.2008.06.001
10.1176/appi.ajp.2008.07101560
10.1016/j.jad.2009.02.028
10.1016/j.jad.2009.02.028
10.1007/s11920-009-0075-0
10.1185/03007991003779380
10.1017/S1461145711000885
Vieta E, 2012, Eur Neuropsychopharmacol, 22, 825, 10.1016/j.euroneuro.2012.03.004
Vieta E, 2012, J Affect Disord, 142, 36, 10.1016/j.jad.2012.04.014
Viguera AC, 2007, J Clin Psychiatry, 68, 29
10.1016/j.eurpsy.2011.06.003
Weisler RH, 2006, CNS Drugs, 20, 219, 10.2165/00023210-200620030-00004
10.1111/j.1399-5618.2009.00665.x
Woo YS, 2011, Hum Psychopharmacol, 26, 543, 10.1002/hup.1240
World Health Organization, 1992, Clinical descriptions and diagnostic guidelines
10.1111/j.1399-5618.2009.00672.x
Yildiz A, 2011, Neuropsychopharmacology, 36, 375, 10.1038/npp.2010.192
10.1176/appi.ajp.161.4.608
Yoshimura R, 2006, Pharmacopsychiatry, 39, 233, 10.1055/s-2006-951386
Young AH, 2011, Br J Psychiatry, 198, 336, 10.1192/bjp.bp.110.082875
10.1016/j.jad.2011.06.016
Young AH, 2012, World J Biol Psychiatry
Zarate CA, 2004, Am J Psychiatry, 161, 169, 10.1176/appi.ajp.161.1.169
Zarate CA, 1995, J Clin Psychiatry, 56, 108
Zhang X, 2011, J Alzheimers Dis, 24, 739, 10.3233/JAD-2011-101875
Zimmerman M, 2012, J Clin Psychiatry, 73, 790, 10.4088/JCP.11m07203
Zis AP, 1980, Psychopharmacol Bull, 16, 47